CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 370443-370657 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2822","span":{"begin":0,"end":214},"obj":"Sentence"},{"id":"T48289","span":{"begin":0,"end":214},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These data demonstrate the superior dose-response of API-1252 as compared to linezolid against HA-MRSA and CA-MRSA in the mouse thigh model. fAUC/MIC appears to best characterise the PD profile of this novel agent."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T219","span":{"begin":0,"end":214},"obj":"Sentence"}],"text":"These data demonstrate the superior dose-response of API-1252 as compared to linezolid against HA-MRSA and CA-MRSA in the mouse thigh model. fAUC/MIC appears to best characterise the PD profile of this novel agent."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T793","span":{"begin":141,"end":214},"obj":"Epistemic_statement"}],"text":"These data demonstrate the superior dose-response of API-1252 as compared to linezolid against HA-MRSA and CA-MRSA in the mouse thigh model. fAUC/MIC appears to best characterise the PD profile of this novel agent."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1229","span":{"begin":98,"end":102},"obj":"Disease"},{"id":"T1230","span":{"begin":110,"end":114},"obj":"Disease"},{"id":"T83851","span":{"begin":98,"end":102},"obj":"Disease"},{"id":"T12048","span":{"begin":110,"end":114},"obj":"Disease"}],"attributes":[{"id":"A1229","pred":"mondo_id","subj":"T1229","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A1230","pred":"mondo_id","subj":"T1230","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A58764","pred":"mondo_id","subj":"T83851","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A86162","pred":"mondo_id","subj":"T12048","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"These data demonstrate the superior dose-response of API-1252 as compared to linezolid against HA-MRSA and CA-MRSA in the mouse thigh model. fAUC/MIC appears to best characterise the PD profile of this novel agent."}